A191182
Acrivastine-d8
| Trivial name | Acrivastine-d8 |
| Catalog Number | TRC-A191182-25MG |
| Alternative Name(s) | (2E)-3-[6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-2-propenoic Acid-d8; BW 0270C-d8; BW 825C-d8; BW A825C-d8; Semprex-d8; (E,E)-3-[6-[1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic Acid-d8; (2E)-3-[6-[1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic Acid-d8 |
| Molecular Formula | C₂₂H₁₆D₈N₂O₂ |
| Inchi | InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+/i2D2,3D2,14D2,15D2 |
| SMILES | O=C(O)/C=C/C1=NC(/C(C2=CC=C(C)C=C2)=C/CN3C([2H])([2H])C([2H])([2H])C([2H])([2H])C3([2H])[2H])=CC=C1 |
| Beilstein Registry Number | NA |
| Size | 25mg |
| Supplier Page | https://www.lgcstandards.com/CA/en/p/TRC-A191182-25MG |